

Episode # 25 • 17 Feb 2026
IVL & Atherectomy: Techniques for Complex PCI
How do imaging, intravascular lithotripsy, and equipment selection come together to effectively target coronary calcium? In this episode of BackTable, interventional cardiologists Dr. Robert Riley (Overlake Medical Center in Bellevue, Washington) and Dr. Yousif Ahmad (UCSF) trade techniques and discuss various aspects of calcium modification in complex percutaneous coronary intervention (PCI).
This podcast is supported by
Timestamps
00:00 - Introduction
04:16 - Complex PCI and Calcium Modification Tools
04:43 - Intravascular Lithotripsy (IVL) Insights and Evolution
12:08 - Calcium Modification Algorithms and Techniques
27:24 - IVUS vs. OCT Imaging and Specialty Balloons
32:12 - Challenges in Implementing New Techniques
37:09 - Influential Studies in Calcium Modification
40:52 - Recent Studies: Short-Cut and VICTORY
53:11 - Future of Calcium Modification Technologies
57:48 - Final Thoughts
Resources
- Dr. Robert Riley
- Dr. Yousif Ahmad
- Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis
- Coronary intravascular lithotripsy for severe coronary artery calcification: The Disrupt CAD I-IV trials
- Orbital Atherectomy vs. Conventional Balloon Angioplasty in Severely Calcified Coronary Arteries Prior to DES Implantation - ECLIPSE
- Shockwave Lithoplasty Compared to Cutting Balloon Treatment in Calcified Coronary Disease - A Randomized Controlled Trial (Short-Cut)
- The Value of IVL Compared To OPN Non-Compliant Balloons for Treatment of RefractorY Coronary Lesions (VICTORY) Trial (VICTORY)
You may also like
More about this episode
The discussion begins with an overview of intravascular lithotripsy (IVL), including its mechanism of action, ideal lesion characteristics, and performance across varying calcium morphologies. The conversation then expands to comparative decision-making among atherectomy, specialty balloons, and IVL, emphasizing how intravascular imaging informs procedural planning and real-time optimization. Key clinical data are reviewed, including the Disrupt CAD I-IV series as well as findings from the Short-Cut and VICTORY trials. The episode concludes with a forward-looking discussion on emerging technologies and the ongoing challenge of treating calcified nodules, one of the most demanding substrates in coronary intervention.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.